BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2011
View Archived Issues
New inverse agonist of glycoprotein hormone TSH receptor with potential to treat Graves' disease
Read More
New data presented on anti-HIV agent BMS-626529 and its prodrug BMS-663068
Read More
Dual antagonist of chemokine CCR2 and CCR5 receptors INCB-10820 is selected for clinical development
Read More
HGN-194 confers cross-clade protection in model of HIV infection
Read More
Inverse docking approach identifies lanosterol synthase as new target for anticancer agents
Read More
AFFiRiS and GSK expand Alzheimer's disease vaccine collaboration
Read More
Amira Pharma claims new lysophospholipid LPA receptor antagonists
Read More
Merck & Co. describes new coagulation factor IXa inhibitors
Read More
Auspex describes novel deuterated ticagrelor derivatives
Read More
Merck KGaA presents novel P70S6K inhibitors
Read More
Neuralstem begins first-in-human study of NSI-189 for major depressive disorder
Read More
National Pharma to license new cytokine GLB-333 from Globe Labs
Read More
RaQualia designs new antagonists of voltage-gated Na(V)1.3 and Na(V)1.7 sodium channels
Read More
Omeros identifies selective interactors of two orphan receptors
Read More
Preflucel influenza vaccine receives European repeat mutual recognition approval
Read More
FDA approves Forest Labs' roflumilast to lower COPD exacerbations and worsening of COPD symptoms
Read More
Intra-Cellular Therapies and Takeda to collaborate on Cam-PDE1 inhibitors
Read More
Osiris Therapeutics completes enrollment in phase II Prochymal trial
Read More
GTx and Ipsen to terminate toremifene collaboration
Read More
Enrollment complete in pivotal Breeze 3 trial of Serada for menopausal hot flashes
Read More
FDA clears Bayhill Therapeutics' IND for BHT-3034 for myasthenia gravis
Read More
FDA issues safety communication on prescription proton pump inhibitor drugs
Read More
Baraclude approved in E.U. for chronic hepatitis B in decompensated liver disease
Read More
Merck Serono receives FDA complete response letter on cladribine tablet NDA
Read More
Clinuvel receives FDA clearance for pilot phase II trial of Scenesse in vitiligo
Read More
